Skip to main content

Peer Review reports

From: Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation

Original Submission
17 Aug 2020 Submitted Original manuscript
21 Oct 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
23 Oct 2020 Editorially accepted
4 Jan 2021 Article published 10.1186/s13063-020-04843-9

You can find further information about peer review here.

Back to article page